2.23
price down icon0.22%   -0.01
 
loading

Maxcyte Inc 주식(MXCT)의 최신 뉴스

pulisher
Jun 18, 2025

MaxCyte Shareholders Approve Equity Plan Amendment - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

MaxCyte shareholders approve equity plan expansion, AIM delisting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Analyzing Ratios: MaxCyte Inc (MXCT)’s Financial Story Unveiled - DWinneX

Jun 18, 2025
pulisher
Jun 13, 2025

California State Teachers Retirement System Sells 82,134 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

MaxCyte Announces Change in Major Holdings by BlackRock - TipRanks

Jun 12, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing By Investing.com - Investing.com South Africa

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte & Ori Biotech Integrate Platforms for Efficient Manufacturing - Contract Pharma

Jun 11, 2025
pulisher
Jun 11, 2025

Market news - investments.halifax.co.uk

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte enters collaboration with Ori Biotech - Sharecast.com

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte (MXCT) Partners with Ori Biotech to Boost Cell Therapy Manufacturing | MXCT Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech partner to enhance cell therapy manufacturing - Investing.com Australia

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Forge Strategic Partnership to Enhance Cell Therapy Manufacturing Efficiency - Nasdaq

Jun 11, 2025
pulisher
Jun 11, 2025

MaxCyte and Ori Biotech Join Forces to Transform CAR-T Cell Production Timeline and Efficiency - Stock Titan

Jun 11, 2025
pulisher
Jun 10, 2025

MaxCyte and Ori Biotech Collaborate to Enhance Cell Therapy Manufacturing - TipRanks

Jun 10, 2025
pulisher
Jun 09, 2025

Kalkine: NASDAQ Today Sees Movement in MaxCyte Amid Sector-Wide Shifts - Kalkine Media

Jun 09, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Decreases Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Purchases Shares of 17,800 MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

MaxCyte (NASDAQ:MXCT) Rating Increased to Hold at Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

MaxCyte Announces Change in Voting Rights Structure - TipRanks

Jun 06, 2025
pulisher
Jun 05, 2025

BlackRock Increases Stake in MaxCyte to 9.98% - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Nuveen Asset Management LLC Cuts Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Has $143,000 Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Takes $56,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

BlackRock Increases Stake in MaxCyte - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

MaxCyte Expands Stock Capital Amidst Strategic Growth - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Jane Street Group LLC Purchases 12,209 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

MaxCyte (NASDAQ:MXCT) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 31, 2025
pulisher
May 31, 2025

Deutsche Bank AG Buys 38,782 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 31, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Buys 84,105 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 27, 2025
pulisher
May 23, 2025

MaxCyte Announces Change in Major Shareholder Voting Rights - TipRanks

May 23, 2025
pulisher
May 23, 2025

BlackRock Increases Stake in MaxCyte, Boosting Voting Rights - TipRanks

May 23, 2025
pulisher
May 19, 2025

BlackRock Increases Stake in MaxCyte to 7.65% - TipRanks

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $177,000 Position in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 18, 2025
pulisher
May 16, 2025

MaxCyte Announces Change in Major Shareholder Holdings - TipRanks

May 16, 2025
pulisher
May 16, 2025

MaxCyte, Inc. (MXCT): A Bull Case Theory - MSN

May 16, 2025
pulisher
May 15, 2025

MaxCyte Inc (MXCT): Be Patient, You Will Learn - Stocksregister

May 15, 2025
pulisher
May 13, 2025

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

MaxCyte’s Earnings Call: Navigating Challenges and Opportunities - TipRanks

May 12, 2025
pulisher
May 12, 2025

William Blair Predicts MaxCyte’s Q2 Earnings (NASDAQ:MXCT) - Defense World

May 12, 2025
pulisher
May 11, 2025

Hsbc Holdings PLC Purchases 16,554 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 11, 2025
pulisher
May 09, 2025

MaxCyte Files Form 10-Q for Q1 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

BTIG cuts MaxCyte stock price target to $5, maintains Buy rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

MaxCyte (MXCT) Upgraded to Buy: Here's What You Should Know - MSN

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: MaxCyte Q1 2025 beats revenue forecast, stock reacts - Investing.com

May 08, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Boosts Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

May 08, 2025
pulisher
May 08, 2025

MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - The Manila Times

May 08, 2025
pulisher
May 08, 2025

MaxCyte Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
$301.27
price down icon 0.32%
medical_devices PHG
$24.16
price down icon 1.51%
medical_devices STE
$237.92
price down icon 0.22%
$84.42
price up icon 0.41%
$76.18
price up icon 0.24%
medical_devices EW
$76.70
price down icon 0.40%
자본화:     |  볼륨(24시간):